FR2509613B1 - Medicament a base d'insuline pour le traitement du diabete sucre - Google Patents

Medicament a base d'insuline pour le traitement du diabete sucre

Info

Publication number
FR2509613B1
FR2509613B1 FR8205186A FR8205186A FR2509613B1 FR 2509613 B1 FR2509613 B1 FR 2509613B1 FR 8205186 A FR8205186 A FR 8205186A FR 8205186 A FR8205186 A FR 8205186A FR 2509613 B1 FR2509613 B1 FR 2509613B1
Authority
FR
France
Prior art keywords
insulin
treatment
based medicine
sugar diabetes
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8205186A
Other languages
English (en)
Other versions
FR2509613A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vnii Ispytatel Med Tech
Original Assignee
Vnii Ispytatel Med Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vnii Ispytatel Med Tech filed Critical Vnii Ispytatel Med Tech
Publication of FR2509613A1 publication Critical patent/FR2509613A1/fr
Application granted granted Critical
Publication of FR2509613B1 publication Critical patent/FR2509613B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Endocrinology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR8205186A 1981-07-14 1982-03-26 Medicament a base d'insuline pour le traitement du diabete sucre Expired FR2509613B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SU813303301A SU1011126A1 (ru) 1981-07-14 1981-07-14 Средство дл лечени сахарного диабета

Publications (2)

Publication Number Publication Date
FR2509613A1 FR2509613A1 (fr) 1983-01-21
FR2509613B1 true FR2509613B1 (fr) 1985-11-15

Family

ID=20963815

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8205186A Expired FR2509613B1 (fr) 1981-07-14 1982-03-26 Medicament a base d'insuline pour le traitement du diabete sucre

Country Status (10)

Country Link
US (1) US4529589A (fr)
JP (1) JPS5813520A (fr)
CA (1) CA1182046A (fr)
CH (1) CH654211A5 (fr)
DE (2) DE3210194A1 (fr)
FR (1) FR2509613B1 (fr)
GB (1) GB2101482B (fr)
IT (1) IT1189255B (fr)
SE (1) SE460096B (fr)
SU (1) SU1011126A1 (fr)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4713239A (en) * 1979-05-29 1987-12-15 Vsesojuny Kardiologichesky Nauchny Tsentr Adkaemii Meditsinski Nauk Sssr Antianginal film and method of treating ischemic heart disease
US4921695A (en) * 1979-05-29 1990-05-01 Babaian Eduard A Antianginal plate for treating ischemic heart disease
US4842854A (en) * 1979-05-29 1989-06-27 Vsesojuzny Kardiologichesky Nauchny Tsentr Akademii Meditsinskiki Nauk Ssr Antianginal plate for treating ischemic heart disease
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета
JPS60224638A (ja) * 1984-04-23 1985-11-09 Kao Corp 経皮吸収促進剤およびこれを含有する外用剤
US5855908A (en) * 1984-05-01 1999-01-05 University Of Utah Research Foundation Non-dissolvable drug-containing dosage-forms for use in the transmucosal delivery of a drug to a patient
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
JPS611621A (ja) * 1984-06-09 1986-01-07 ヘキスト・アクチエンゲゼルシヤフト インシュリン製剤
DE3443877A1 (de) * 1984-06-09 1985-12-12 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung
DE3576120D1 (de) * 1984-06-09 1990-04-05 Hoechst Ag Insulinzubereitungen, verfahren zu deren herstellung und deren verwendung.
US5132114A (en) * 1985-05-01 1992-07-21 University Of Utah Research Foundation Compositions and methods of manufacture of compressed powder medicaments
US5288497A (en) * 1985-05-01 1994-02-22 The University Of Utah Compositions of oral dissolvable medicaments
US4885173A (en) * 1985-05-01 1989-12-05 University Of Utah Methods and compositions for noninvasive dose-to-effect administration of drugs with cardiovascular or renal vascular activities
US5122127A (en) * 1985-05-01 1992-06-16 University Of Utah Apparatus and methods for use in administering medicaments by direct medicament contact to mucosal tissues
US4764378A (en) * 1986-02-10 1988-08-16 Zetachron, Inc. Buccal drug dosage form
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
CA1257199A (fr) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation contenant une substance macromoleculaire ayant des proprietes biologiques liberee pendant plusieurs mois in vivo
JPH0653634B2 (ja) * 1989-01-13 1994-07-20 三菱マテリアル株式会社 シリコン単結晶引上げ用石英ルツボの再生方法
US5064637A (en) * 1989-05-30 1991-11-12 Board Of Regents, The University Of Texas System Substituted sulfonamide derivatives which inhibit allergic reactions
IL99699A (en) 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
FR2797767B1 (fr) * 1999-08-27 2002-06-14 Centre Nat Rech Scient Utilisation d'acides amines pour la fabrication de medicaments destines au traitement des insulino-resistances
AU2000255261A1 (en) * 2000-05-26 2001-12-11 C.T.P. Cable Technology Procurement Ag Means for maintenance and/or correction of glucose concentration in blood
AU2001285489A1 (en) * 2000-08-29 2002-03-13 Nobex Corporation 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith
WO2006095822A1 (fr) * 2005-03-11 2006-09-14 Ono Pharmaceutical Co., Ltd. Compose sulfonamide et produit pharmaceutique le contenant

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1547515A (en) * 1923-07-09 1925-07-28 John R Murlin Antidiabetic substance and method of preparing the same
US2474729A (en) * 1945-01-03 1949-06-28 Rhone Poulenc Sa Insulin preparations
US2789080A (en) * 1952-08-14 1957-04-16 Christensen Henry Marinus Insulin-albumin compositions
DE1017323B (de) * 1952-08-14 1957-10-10 Roskilde Medical Company Ltd Verfahren zur Herstellung von insulinhaltigen Praeparaten mit protrahierter Wirkung
US3060093A (en) * 1957-07-18 1962-10-23 Nordisk Insulinlab Slowly acting insulin preparation in crystalline form and method of preparation
FR1383389A (fr) * 1963-02-20 1964-12-24 Schenley Ind Inc Préparation de colle pour dentiers
US3312594A (en) * 1963-06-21 1967-04-04 Squibb & Sons Inc Longlasting troche
GB1083896A (en) * 1964-04-30 1967-09-20 Dunster Lab Ltd Vehicles for administering drugs
GB1142325A (en) * 1965-05-14 1969-02-05 Higham Stanley Russell Means for administering drugs
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose
SU504766A1 (ru) * 1970-06-18 1976-02-28 Всесоюзный Научно-Исследовательский Химико-Фармацевтический Институт Имени С.Орджоникидзе Способ получени 5- п-/ -/6метоксипиридазинил-3/ -сульфонамидо/ фенилазо -салициловой кислоты
US3847890A (en) * 1971-11-01 1974-11-12 A Green Acidic monosaccharide-substituted proteins
US3978201A (en) * 1972-11-27 1976-08-31 Gennady Lvovich Khromov Base for ophthalmological medicinal preparation on opthalmological medicinal film
JPS5138412A (en) * 1974-09-24 1976-03-31 Nippon Kayaku Kk Kokoseizai no seiho
DK143689C (da) * 1975-03-20 1982-03-15 J Kreuter Fremgangsmaade til fremstilling af en adsorberet vaccine
US4153689A (en) * 1975-06-13 1979-05-08 Takeda Chemical Industries, Ltd. Stable insulin preparation for nasal administration
GB1563311A (en) * 1975-09-26 1980-03-26 Yamanouchi Pharma Co Ltd Pharmaceutical composition of insulin for rectal use
SU810241A1 (ru) * 1978-03-03 1981-03-07 Всесоюзный Кардиологический Научныйцентр Способ индивидуального дозировани плЕНОчНыХ фОРМ лЕКАРСТВЕННыХСРЕдСТВ
SU806037A1 (ru) * 1978-04-06 1981-02-23 Всесоюзный Кардиологический Научныйцентр Amh Cccp Антиангинальное средство
JPS5562012A (en) * 1978-11-06 1980-05-10 Teijin Ltd Slow-releasing preparation
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
EP0018609B1 (fr) * 1979-04-30 1983-09-21 Hoechst Aktiengesellschaft Solutions aqueuses de protéines, stables à la dénaturation, procédé pour leur fabrication et leur utilisation
DE2917535C2 (de) * 1979-04-30 1986-10-30 Hoechst Ag, 6230 Frankfurt Gegen Denaturierung beständige Insulinlösungen
JPS55153712A (en) * 1979-05-18 1980-11-29 Kao Corp Insulin pharmaceutical preparation and its production
SU1011126A1 (ru) * 1981-07-14 1983-04-15 Всесоюзный научно-исследовательский и испытательный институт медицинской техники Средство дл лечени сахарного диабета

Also Published As

Publication number Publication date
IT8248200A0 (it) 1982-04-08
CA1182046A (fr) 1985-02-05
GB2101482A (en) 1983-01-19
SE8201784L (sv) 1983-01-15
SE460096B (sv) 1989-09-11
JPS5813520A (ja) 1983-01-26
IT1189255B (it) 1988-02-04
DE3226363C2 (fr) 1987-01-08
DE3210194A1 (de) 1983-02-03
FR2509613A1 (fr) 1983-01-21
GB2101482B (en) 1984-08-01
SU1011126A1 (ru) 1983-04-15
CH654211A5 (de) 1986-02-14
DE3226363A1 (de) 1983-06-01
US4529589A (en) 1985-07-16

Similar Documents

Publication Publication Date Title
FR2509613B1 (fr) Medicament a base d'insuline pour le traitement du diabete sucre
FR2508318B1 (fr) Bandage pour l'administration d'une substance pharmaceutique
FR2574292B1 (fr) Dispositif osmotique pour l'apport programme de medicaments
FR2550452B1 (fr) Dispositif pour administrer des medicaments a des patients
DK156376C (da) Anvendelse af ibogain til fremstilling af et laegemiddel til behandling af narkotikamisbrug
IT8222228A0 (it) Dispositivo per l'infusione di un medicamento.
IT8521230A0 (it) Dispositivo per l'immissione mediante fleboclisi di liquidi medicinali in un paziente.
BE865806R (fr) Dispositif pour l'inhalation de medicament
BE884640A (fr) Dispositif de raccordement rotatif pour ensemble d'administration intraveineuse
BE883100A (fr) Regulateur d'ecoulement implantable, notamment pour l'infusion de medicaments
FR2585563B1 (fr) Dispositif pour administrer des medicaments a des patients
FR2574291B1 (fr) Dispositif osmotique pour apporter un medicament au niveau du colon
ZA829335B (en) Pharmaceutical preparation for treating alzheimer's disease
FR2560044B1 (fr) Dispositif therapeutique osmotique pour l'apport de medicaments
FR2482588B1 (fr) Composition pharmaceutique pour le traitement du diabete sucre juvenile
FR2503716B1 (fr) Procede pour la preparation d'elastomeres acryliques reticules
BE867919A (fr) Dispositif pour l'administration de substances medicamenteuses
JPS57114508A (en) Pharmaceutical medicine for use of choline- action suppressive drug
MA26522A1 (fr) Composition pharmaceutique pour le traitement du diabete sucre et d'etats associes.
FR2574295B1 (fr) Medicaments a base de gluconate de zinc utiles pour le traitement des hyperprolactinemies
ZA825302B (en) Medicine for the treatment of diabetes
BE894228A (fr) Composition pharmaceutique pour le traitement de l'atherosclerose
BE894101A (fr) Dispositif pour l'inhalation de medicaments
BE888324A (fr) Medicament pour favoriser la guerison du diabete.
ZA822176B (en) Pharmaceutical compositions for the treatment of diabetes

Legal Events

Date Code Title Description
ST Notification of lapse